Back to search

National and Kapodistrian University of Athens

Μελέτη της μικροδορυφορικής αστάθειας, των ενζύμων επιδιόρθωσης του DNA και του μονοπατιού της MAP κινάσης στον καρκίνο της ουροδόχου κύστεως

Abstract

dc:description

Aim of this study is the molecular and immunohistochemical study of urothelial bladder carcinomas, as well as the correlation with their clinicopathological characteristics and patients survival, in order to determine the potential association of these alterations in likely prognostic and diagnostic methods but also as means of follow-up of the disease. We studied MSI target genes TGF-βRII(A)₁₀, IGFIIR(G)₈, BAX(G)₈, caspase 5(Α)₁₀, hMSH3(A)₈ and hMSH6(G)₈ for the presence of mutations in their mononucleotide sequences and hMLH1, hMSH2 protein expression. We also analysed the presence of B-Raf gene mutations in relation to the activation of MAP kinase ERK. Molecular biology methods as well as immunohistochemistry were used in 152 tumor samples from patients with primary UC. At the present study 11 cases (16%) were mutated at TGF-βRII(A)₁₀, 1 case (3%) at BAX(G)₈ while no mutations were observed in caspase 5(A)₁₀, hMSH3(A)₈, hMSH6(G)₈ and IGFIIR(G)₈ by using PCR-SSCP and sequencing analysis. Nuclear hMLH1 and hMSH2 protein expression was found in 40/65 and 38/62 of the cases respectively by immunohistochemistry. Mutations in exon 15 of B-Raf gene were not detected in any of the examined cases. Nuclear or cytoplasmic immunoreactivity for pERK was detected in 99.3% (151/152) and 96.7% (147/152) of cases respectively. According to our results frameshift mutations at mononucleotide repeats in target genes of the microsatelhte instability pathway in urothelial carcinomas of the bladder are rarely observed in urinary bladder carcinogenesis in which the MSI pathway is rather uncommon. Nevertheless, hMLH1 protein expression is related to the presence of MSI and it is an important indicator for disease recurrence. Elevated pERK expression is observed in UCs in absence of B-Raf mutations. Interestingly, nuclear pERK expression parallels histologic grade and T-category in bladder UCs, implicating ERK activation in tumor invasiveness as well as in the acquisition of a more aggressive phenotype. These results speak in favor of the role of activated ERK as a molecular marker in the development of bladder cancer and encourage prospective investigations to validate the role of pERK as a therapeutic target in urothelial bladder cancer.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Κάρλου, Μαρία
  • Karlou, Maria

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24421

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Κάρλου, Μαρία; Karlou, Maria. Μελέτη της μικροδορυφορικής αστάθειας, των ενζύμων επιδιόρθωσης του DNA και του μονοπατιού της MAP κινάσης στον καρκίνο της ουροδόχου κύστεως. National and Kapodistrian University of Athens, 2008. http://hdl.handle.net/10442/hedi/24421